AUA Live Saturday (2020)

AUA Live is a virtual meeting and will include 65 sessions with over 165 speakers, panelists and moderators. Vendors have been selected to schedule and record the sessions in advance and provide the platform for AUA Live. The “live” component will consist of moderators responsible for responding to the Live Chat feedback and questions.

Acknowledgements

The American Urological Association would like to thank the following companies for providing independent educational grants in support of AUA Live:

  • Astellas
  • AstraZeneca
  • Bristol-Myers Squibb
  • Intuitive
  • Lumenis, Inc.
  • Merck
  • Pfizer, Inc.
  • Photocure Inc.
  • PROCEPT BioRobotics
  • Sanofi Genzyme
  • Teleflex
  • Zhuhai Pusen Medical Technology Co., Ltd.

Target Audience

  • Urologist
  • Resident
  • Advanced Practice Provider (Nurse Practitioners & Physician Assistants)

Learning Objectives

At the conclusion of the AUA Live program, participants will be able to:

  1. Describe recent developments in the medical and surgical management of urology patients.
  2. Identify new technologies for the treatment of urologic conditions.
  3. Integrate the latest guidelines on the management of urological diseases into their practice.
Course summary
Available credit: 
  • 6.75 AMA PRA Category 1 Credit™
  • 6.75 Non-Physician Participation
Course opens: 
06/29/2020
Course expires: 
06/28/2023
Parent activity set: 
Rating: 
0

Saturday, June 27, 2020  

Theater One

10 – 10:05 a.m.
Plenary Introduction
AUA Secretary: John Denstedt, MD

10:05 – 10:20 a.m.
Presidential Address
AUA President: John Lynch, MD

10:20 – 10:40 a.m.
Ramon Guiteras Lecture: Active Surveillance for Low and Intermediate Prostate Cancer – The Past or the Future?
Presenter: Peter Carroll, MD

10:40 – 11:10 a.m.
Crossfire: Controversies in Urology: Prostate Cancer Active Surveillance can be done with mpMRI and Biomarkers; Biopsies are no Longer Necessary
Moderator: Christopher Evans, MD
Debaters-Pro: Mark Emberton, MD; Eric Klein, MD
Debaters-Con: William Catalona, MD; Samir Taneja, MD

11:10 – 11:30 a.m.
Break

11:30 a.m. – Noon
Featured Speaker: Anthony Fauci, MD

Noon —12:30 p.m.
Second Opinion Cases: Distal Penile Cancer: Options to Partial Penectomy
Moderator: Curtis Pettaway, MD
Panelists: Philippe Spiess, MD; R. Jeffery Karnes, MD; Karen Hoffman, MD

12:30 – 12:45 p.m.
AUA Guidelines 2020: Advanced Prostate Cancer
Presenters: Michael S. Cookson, MD, MMHC & William Lowrance, MD

12:45 – 1:15 p.m.
AUA Guidelines Case-Based Panel Discussion: Bladder Cancer (Non-muscle and Muscle Invasive)
Moderator: Sam S. Chang, MD
Panelists: Sima Porten, MD; Joshua Meeks, MD; Elizabeth Plimack, MD; Ronald Chen, MD, MPH

1:15 – 1:45 p.m.
Panel Discussion: What to Do During BCG Shortage for High-risk NMIBC Patients?
Moderator: Seth Lerner, MD
Panelists: Ashish Kamat, MD; Steve Boorjian, MD; James McKiernan, MD; Chad Ritch, MD

1:45 – 2 p.m.
Surgical Techniques: Tips & Tricks: Oncology: Bladder Cancer Blue Light
Presenter: Anne Schuckman, MD

2 – 3 p.m.
Surgical Techniques: Tips & Tricks: Robotics

Single Port Extraperitoneal Prostatectomy
Presenter: Jihad Kaouk, MD

Reducing Variation; Standardized Surgical Technique for Radical & Partial Nephrectomy
Presenter: Ketan Badani, MD

Retroperitoneal Partial Nephrectomy with IRIS (IRIS is integrated CT imaging)
Presenter: Michael Stifelman, MD

Complex Partial Nephrectomy
Presenter: Li-Ming Su, MD

3 – 3:45 p.m.
International Prostate Forum: Best of Washington, DC
Moderators: John W. Davis, MD & Neal Shore, MD
Why Precision Matters: Implications of genomic analysis for mCRPC: James Gulley, MD
PSMA radioligand therapy: A new modality approaches: Kenneth Pienta, MD
Reviewing the current indispensable role of Prostate MRI: Peter Pinto, MD

3:45 – 4 p.m.
AUA Guidelines 2020: Microhematuria
Presenters: Dan Barocas, MD & Stephen Boorjian, MD

4 – 4:20 p.m.
Journal of Urology Lecture: Use of Web and Social Media Sources for Physician Education
Presenter: John W. Davis, MD

4:20 – 4:45 p.m.
Panel Discussion: Genetic Testing: What the Urologist Needs to Know
Moderator: Leonard Gomella, MD
Panelists: Kevin Loughlin, MD; Todd Morgan, MD; Veda Giri, MD


Theater Two

10 – 10:05 a.m.
Plenary Introduction
AUA Secretary: John Denstedt, MD

10:05 – 10:20 a.m.
Presidential Address
AUA President: John Lynch, MD

10:20 – 10:50 a.m.
Crossfire: Controversies in Urology: Pre-emptive URS (or SWL) vs. Active surveillance for Non-Obstructing 8 mm Renal Stones
Moderator: Michelle J. Semins, MD
Debaters: Necole Streeper, MD; Carley Davis, MD; Patrick Mufarrij, MD; Ryan Hsi, MD

10:50 – 11:20 a.m.
Crossfire: Controversies in Urology: Single use Ureteroscope: Should They be Used All of the Time?
Moderator: Bodo Knudsen, MD
Debaters-Pro (all of the time): Thomas Chi, MD; Michael Lipkin, MD
Debaters-Con (some of the time): Olivier Traxer, MD; Guido Giusti, MD

11:20 – 11:30 a.m.
Break

11:30 – Noon
Featured Speaker: Anthony Fauci, MD

Noon – 12:30 p.m.
Nightmares in Endourology
Moderator: Arthur Smith, MD
Panelists: Margaret Pearle, MD; Stephen Nakada, MD; Marshall Stoller, MD; James Lingeman, MD; Ojas Shah, MD

12:30 – 12:55 p.m.
Panel Discussion: Obesity and Stone Disease
Moderator: Dean Assimos, MD
Panelists:
Effect on Urine pH: Naim Maalouf, MD
Effect of Urinary Calcium: Brian Matlaga, MD
Effect on Urinary Oxalate: Kyle Wood, MD

12:55 – 1:10 p.m.
State-of-the-Art Lecture: The New Thulium Fiber Laser: What is New and How is it Used?
Presenter: Peter Kronenberg, MD

1:10 – 1:40 p.m.
Crossfire: Controversies in Urology: Diet Versus Medical Therapy for Stone Prevention
Moderator: Glenn M. Preminger, MD
Debaters (Diet): Patrick S. Lowry, MD; Kristina L. Penniston, PhD
Debaters (Medical): David S. Goldfarb, MD; George Haleblian, MD

1:40 p.m. – 2:45 p.m.
Semi-Live Surgeries & Surgical Techniques Tips & Tricks: PCNL/URS
Flexible Ureteroscopy with Laser: Khurshid Ghani, MD
Single-Use Digital Flexible Ureteroscope: Duane Baldwin, MD
PCNL with Trilogy (Modern Day Lithotrite for Cystolitholapaxy): Amy Krambeck, MD
Laser Stone Fragmentation: Ben Chew, MD

2:45 – 3 p.m.
Confederacion Americana de Urologia (CAU) Lecture: Is Mini-PERC the New Standard for Percutaneous Nephrolithotomy?
Presenter: Jorge Gutierrez Aceves, MD

3 – 3:30 p.m.
Panel Discussion: Pain Management in Urologic Surgery
Moderator: Angela M. Smith, MD, MS, FACS
Panelists: Jay Simhan, MD, FACS; Nicole L. Miller, MD, FACS; Ben J. Davies, MD

3:30 – 3:50 p.m.
John K. Lattimer Lecture: The Urinary Microbiome Impacts Urologic Disease
Presenter: J. Curtis Nickel, MD

3:50 – 4:10 p.m.
State-of-the-art Lecture: Has EMR Improved Patient Care?
Presenter: Peter Basch, MD

4:10 – 4:25 p.m.
State-of-the-Art Lecture: Urologists' Prescribing Practices cause Dementia—or Do They?
Moderator: Tomas Griebling, MD

4:25 – 4:55 p.m.
Crossfire: Controversies in Urology: Robotic Kidney Transplantation
Moderator: Alp Sener, MD
Debater-Pro: Alberto Breda, MD
Debater-Con: Kenneth Pace, MD


Theater Three (Non-CME)

10 – 11 a.m.
BPH treatment: meds, MIST, and the Future
Speaker: Daniel B. Rukstalis, MD
Description: New advances for treating BPH will be discussed including: Challenging the approach to medical therapy; Goals for minimally invasive surgical therapy, and Clinical updates for the UroLift System

Sponsored by: NeoTract/Teleflex Inc.

11 a.m. – Noon
A Deeper Dive into the Use of Myrbetriq® (mirabegron) in Patients 65 and Older with OAB Symptoms of Urge Urinary Incontinence, Urgency, and Urinary Frequency
Speaker: David Staskin, MD

Sponsored by: Astellas Pharma US, Inc.

Noon – 1 p.m.
Learn More About Evidence-Based Changes in the Metastatic Castration-Sensitive Prostate Cancer Treatment Landscape
Speaker: Ken Kernen, MD

Sponsored by: Astellas & Pfizer

1 – 2 p.m.
Treating Patients with Advanced Prostate Cancer: mCSPC
Speaker: Robert Reiter, MD – UCLA Medical Center

Sponsored by: Janssen Biotech, Inc.

2 – 3 p.m.
The MOSES Technology – A proven innovation for urinary stones and BPH treatments
Speakers: Mantu Gupta MD – Professor of Urology, Icahn School of Medicine at Mount Sinai, New York, NY; Roger Sur MD – Professor of Urology, UC San Diego, CA; Tim Large MD – Assistant Professor of Urology, Indiana University, IN
Description: The MOSES Technology is redefining urology care worldwide. With 20% faster procedures and up to 2.6 greater fragmentation rate in lithotripsy, as well as 15% faster enucleation and over 90% of patients discharged on the day of surgery – MOSES provides a proven and ongoing innovation for Urology professionals.

Sponsored by: Lumenis

3 – 4 p.m.
Commercial Genomic Assays for Localized Prostate Cancer: How Do They Compare?
Speaker: Robert Reiter, MD ‐ UCLA
Description: This webinar will compare how tissue-based genomic assays have been validated to predict long and short-term outcomes and if the results can help guide the active surveillance decision in low and favorable-intermediate risk patients.

Sponsored by: Exact Sciences – Oncotype DX

All persons in a position to control the content of this educational activity (i.e., activity planners, speakers, moderators) were required to disclose to the provider any relevant financial relationships with any commercial interest.    

PDF iconView Planning Committee Disclosures

PDF iconView Speaker and Moderator Disclosures

Note: Only individuals that attended the Live Program on Saturday, June 27, 2020 may claim credit for their participation.  

ACCREDITATION: 

The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CREDIT DESIGNATION: 

The American Urological Association designates this live activity for a maximum of 6.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

OTHER LEARNERS: 

The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.

EVIDENCE BASED CONTENT: 

It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

AUA DISCLOSURE POLICY: 

All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.

RESOLUTION OF IDENTIFIED CONFLICT OF INTEREST: 

All disclosures will be reviewed by the AUA Conflict of Interest (COI) Review Work Group for identification of conflicts of interest. The AUA COI Review Work Group, working with the program directors and/or editors, will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:

  • Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director, editor, and/or AUA COI Review Work Group.
  • Limit content to evidence with no recommendations
  • Introduction of a debate format with an unbiased moderator (point-counterpoint)
  • Inclusion of moderated panel discussion
  • Publication of a parallel or rebuttal article for an article that is felt to be biased
  • Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
  • Divestiture of the relationship by faculty

OFF-LABEL OR UNAPPROVED USE OF DRUGS OR DEVICES: 

The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.


AUA Participant Information and Policies

DISCLAIMER:

The opinions and recommendations expressed by faculty, authors and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the AUA.

AUDIO, VIDEO AND PHOTOGRAPHIC EQUIPMENT:

The use of audio, video and other photographic recording equipment by attendees is prohibited inside AUA meetings.

REPRODUCTION PERMISSION: 

Reproduction of written materials developed for this AUA course is prohibited without the written permission from individual authors and the American Urological Association.

Available Credit

  • 6.75 AMA PRA Category 1 Credit™
  • 6.75 Non-Physician Participation
Please login or register to take this course.

Recordings from the AUA Live may be viewed by clicking the "Take Course" button.

*Note: Video recordings will be available until Monday, June 28, 2021. 

If you attended the live program, you may also click the "Take Course" button to complete the evaluation and claim credit.

*Note: Only individuals that attended the live course are eligible to claim credit.